Company Overview

AI/ML Innovations Inc. (OTCQB: AIMLF; CSE: AIML) is a Canada-based technology company focused on artificial intelligence (AI), machine learning (ML), digital health, and remote patient monitoring solutions. The company operates primarily in the healthcare technology sector, with an emphasis on AI-enabled health analytics, predictive monitoring, and wearable or sensor-driven healthcare applications. Public filings and investor materials describe the company as pursuing commercialization opportunities in digital health platforms that combine machine learning models with clinical and physiological data.

The company’s principal business strategy has centered on acquiring, developing, and supporting technology subsidiaries involved in health monitoring, clinical decision support, and AI-driven wellness applications. Revenue generation has historically been limited relative to larger public technology firms, with operations focused more heavily on product development, commercialization partnerships, and intellectual property expansion. AI/ML Innovations evolved through a holding-company structure that assembled interests in multiple healthcare and AI-related ventures, positioning itself within the growing digital therapeutics and remote care markets.

Business Operations

AI/ML Innovations conducts operations through a portfolio model that includes ownership interests in healthcare and AI-focused businesses. Public disclosures have identified subsidiaries and portfolio interests including Health Gauge Inc., which has focused on AI-supported health monitoring applications, and other affiliated technology initiatives associated with digital diagnostics and physiological analytics. The company’s business model has included software development, commercialization licensing, strategic equity ownership, and partnerships related to healthcare data analysis and remote monitoring systems.

Operations have primarily been concentrated in Canada and the United States, although the company has referenced broader commercialization ambitions in international digital health markets. Its technology interests involve mobile applications, cloud-based analytics, biometric monitoring, and machine learning systems designed to assist with early detection of health risks and patient engagement. Based on available public filings, the company has remained in a development and scaling phase, with no evidence of large-scale diversified operating divisions comparable to major multinational technology firms.

Strategic Position & Investments

AI/ML Innovations has positioned itself around the convergence of AI, preventive healthcare, and remote patient monitoring. Strategic initiatives described in company disclosures have included investment in machine learning-driven healthcare analytics, expansion of wearable-enabled monitoring capabilities, and collaboration with healthcare technology developers. The company has also pursued acquisition and equity participation strategies to broaden its exposure to digital health innovation and intellectual property assets.

The company’s investment strategy has emphasized emerging healthcare technologies rather than traditional enterprise software markets. Publicly referenced investments and operating interests have included Health Gauge Inc. and related digital health ventures associated with biometric data analysis and predictive health scoring. Available public information indicates that the company has focused on long-term commercialization potential in AI healthcare applications, though publicly available financial filings suggest that many initiatives remain in relatively early-stage commercialization phases. Data regarding large-scale institutional partnerships or major transformative acquisitions remains limited based on available public sources.

Geographic Footprint

AI/ML Innovations is headquartered in Canada, with corporate activities and public listings tied to Canadian capital markets, including the Canadian Securities Exchange. The company also maintains visibility in the United States through its OTC market listing under the ticker AIMLF. Its operational and strategic focus has primarily targeted North American healthcare technology opportunities.

The company’s market presence outside North America appears limited based on currently available public disclosures. However, investor communications and strategic materials have referenced scalable digital health applications that could potentially support broader international deployment. No substantial evidence from public filings confirms major operational hubs, manufacturing centers, or large-scale international subsidiaries beyond its North American footprint.

Leadership & Governance

AI/ML Innovations has been led by executives with backgrounds in technology commercialization, healthcare innovation, and capital markets. Governance information has been disclosed through company filings, investor presentations, and regulatory announcements. Leadership strategy has emphasized building a portfolio of AI-enabled healthcare technologies and advancing commercialization opportunities within preventive medicine and remote monitoring.

Key executives and leadership figures publicly associated with the company include:

• Tim Daniels – Chief Executive Officer
• Paul Duffy – Executive Chairman
• Dennis Becker – Director
• Peter Kendall – Director

Public disclosures indicate that leadership has focused on strategic investment in digital health technologies, partnership development, and shareholder value creation through expansion of AI-driven healthcare applications. Some executive and board composition details have changed over time across filings and announcements; where discrepancies exist between historical disclosures and current public materials, data remains inconclusive based on available public sources.